Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses.
about
Enhancing oral vaccine potency by targeting intestinal M cellsA Brief Review of Computer-Assisted Approaches to Rational Design of Peptide VaccinesReport from the field: Fifth Vaccine Renaissance in Providence RI.PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.Epitope design of L1 protein for vaccine production against Human Papilloma Virus types 16 and 18In silico identification of epitopes from house cat and dog proteins as peptide immunotherapy candidates based on human leukocyte antigen binding affinity.Identification of novel conserved functional motifs across most Influenza A viral strainsCharacterization of a branched lipopeptide candidate vaccine against influenza A/Puerto Rico 8/34 which is recognized by human B and T-cell immune responses.Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose.Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially.The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approachesHIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine DevelopmentT-cell epitope vaccine design by immunoinformatics.Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and productionPrediction of anti-inflammatory proteins/peptides: an insilico approach.Computer-aided design of T-cell epitope-based vaccines: addressing population coverage.Recent advances in the molecular design of synthetic vaccines.A Cohesive and Integrated Platform for Immunogenicity Prediction.T-cell epitopes predicted from the Nucleocapsid protein of Sin Nombre virus restricted to 30 HLA alleles common to the North American population.Molecular modeling and in-silico engineering of Cardamom mosaic virus coat protein for the presentation of immunogenic epitopes of Leptospira LipL32.Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.The use of databases, data mining and immunoinformatics in vaccinology: where are we?
P2860
Q21089613-046ADA12-8C3E-4C33-8296-AABFC907004AQ24261117-F9D57E87-AD6A-4B9B-A8BB-0C4973D62A7CQ30418986-8EAE1054-337C-496F-831E-709D665A0406Q31111090-79FBB1FF-DB4C-46B3-A249-647CCC477ACFQ33743226-1EB18E92-B4BF-44DF-9D55-13455A677C5CQ33754444-30424376-EDFC-4618-87EC-648BD77165FEQ34564391-0D715844-C481-424B-A414-759B2AFF5BC9Q35133760-D0B9A77B-D328-42AC-824A-BAEAF07A4E82Q35869228-DDA6B2FD-EE77-4454-9DCE-714B665ED6A4Q36249053-3D887666-E2CE-4F14-A18C-CB4822F1880DQ36603325-CD6B9699-9E38-434B-BDFE-CFF4264FE3DCQ36651031-094E08D1-8729-4897-860D-8B331D7AFAE8Q36702419-1EE2071D-CD91-40E4-9F64-EEF19B4A6760Q37134971-02BD1044-C716-4E47-ACFD-4B93BB1DA517Q37563960-FDDB12BA-0267-48E3-97DC-DEE9E8B128D0Q38554524-6C87FE88-14B5-4303-A55A-3B613BD3A410Q38639938-98667C3A-59D9-409A-BD9A-7D3792F77223Q39852556-B4B621C9-454A-461C-8FB7-925B51863F17Q40171653-4BBE556E-E901-474D-B73A-99614E9BCE40Q42161940-C43EDB4B-7A22-4889-8FAF-8EFAF2DEEAB2Q43518287-24F2FFA2-E173-4BBE-87EA-D04634633F2CQ47262746-30296FCD-4685-4DBF-B742-EBBBA9F89B19
P2860
Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Innovative bioinformatic appro ...... against hypervariable viruses.
@en
Innovative bioinformatic appro ...... against hypervariable viruses.
@nl
type
label
Innovative bioinformatic appro ...... against hypervariable viruses.
@en
Innovative bioinformatic appro ...... against hypervariable viruses.
@nl
prefLabel
Innovative bioinformatic appro ...... against hypervariable viruses.
@en
Innovative bioinformatic appro ...... against hypervariable viruses.
@nl
P2093
P2860
P356
P1476
Innovative bioinformatic appro ...... against hypervariable viruses.
@en
P2093
Ashkan Golshani
Ashok Kumar
Danylo Sirskyj
Francisco Diaz-Mitoma
P2860
P356
10.1038/ICB.2010.65
P577
2010-05-11T00:00:00Z